leisure time -WSS

leisure time

author：explore 2025-09-30 17:27:18 - browse：2

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Beware the threat of staffing cuts at the CDC

WSS

Affirmative action in medical school literally saved lives

Activists slam private health insurers over coverage restrictions

An interview with Robert F. Kennedy Jr. on vaccines

Hilary expected to bring catastrophic, life

Sports medicine is finally prioritizing gender equality

Congress must give Medicare recipients genetic counseling access

leisure time

leisure time

focus

Guidelines to prevent youth baseball injuries need more muscle

ActiGraph execs on goal of drug approvals with digital endpoints

Heart attack and stroke risk calculators need revising

Continuity nursing helped my family in our darkest PICU moments

Hollywood unions extend contract negotiations for actors

What does generative AI mean for health care? We asked experts

DIEP, the 'gold standard' of breast reconstruction, is under threat

Duchenne breakthrough therapy leaves behind pioneering families

Bright Health sells Medicare Advantage business to Molina

Beware the threat of staffing cuts at the CDC

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Evacuations in place as 3 wildfires burn in eastern Washington state

Living with Hashimoto's and celiac disease, and med school, too

Eye stem cell transplant could help restore vision in injured people

At least 13 dead in Texas as scorching temps continue

New definition of a human embryo proposed amid rapid advances

hotspot

leisure time

hotspot

focus